How to address racial disparities in clinical trial data

In the US, fewer than three per cent of eligible patients participate in clinical trials – a figure that drops drastically when applied to ethnic minorities living in underserved communities.

It’s a problem that has repercussions across the healthcare ecosystem, and the impact of disparity on the medical evidence base will only magnify as we further move into the personalised care era.